394 related articles for article (PubMed ID: 28855138)
21. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM
PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615
[TBL] [Abstract][Full Text] [Related]
22. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY
J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013
[TBL] [Abstract][Full Text] [Related]
23. Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.
McCrudden MT; Torrisi BM; Al-Zahrani S; McCrudden CM; Zaric M; Scott CJ; Kissenpfennig A; McCarthy HO; Donnelly RF
J Pharm Pharmacol; 2015 Mar; 67(3):409-25. PubMed ID: 24673568
[TBL] [Abstract][Full Text] [Related]
24. Microneedles for intradermal and transdermal drug delivery.
Tuan-Mahmood TM; McCrudden MT; Torrisi BM; McAlister E; Garland MJ; Singh TR; Donnelly RF
Eur J Pharm Sci; 2013 Dec; 50(5):623-37. PubMed ID: 23680534
[TBL] [Abstract][Full Text] [Related]
25. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.
Prausnitz MR
Annu Rev Chem Biomol Eng; 2017 Jun; 8():177-200. PubMed ID: 28375775
[TBL] [Abstract][Full Text] [Related]
26. Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.
Littauer EQ; Mills LK; Brock N; Esser ES; Romanyuk A; Pulit-Penaloza JA; Vassilieva EV; Beaver JT; Antao O; Krammer F; Compans RW; Prausnitz MR; Skountzou I
J Control Release; 2018 Apr; 276():1-16. PubMed ID: 29496540
[TBL] [Abstract][Full Text] [Related]
27. Microneedle patches: usability and acceptability for self-vaccination against influenza.
Norman JJ; Arya JM; McClain MA; Frew PM; Meltzer MI; Prausnitz MR
Vaccine; 2014 Apr; 32(16):1856-62. PubMed ID: 24530146
[TBL] [Abstract][Full Text] [Related]
28. Successful application of large microneedle patches by human volunteers.
Ripolin A; Quinn J; Larrañeta E; Vicente-Perez EM; Barry J; Donnelly RF
Int J Pharm; 2017 Apr; 521(1-2):92-101. PubMed ID: 28216463
[TBL] [Abstract][Full Text] [Related]
29. Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development.
Adhikari BB; Goodson JL; Chu SY; Rota PA; Meltzer MI
Drugs R D; 2016 Dec; 16(4):327-338. PubMed ID: 27696306
[TBL] [Abstract][Full Text] [Related]
30. Adenosine-loaded dissolving microneedle patches to improve skin wrinkles, dermal density, elasticity and hydration.
Kang G; Tu TNT; Kim S; Yang H; Jang M; Jo D; Ryu J; Baek J; Jung H
Int J Cosmet Sci; 2018 Apr; 40(2):199-206. PubMed ID: 29574973
[TBL] [Abstract][Full Text] [Related]
31. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design.
Chen MC; Lai KY; Ling MH; Lin CW
Acta Biomater; 2018 Jan; 65():66-75. PubMed ID: 29109028
[TBL] [Abstract][Full Text] [Related]
32. Rabies vaccination in dogs using a dissolving microneedle patch.
Arya JM; Dewitt K; Scott-Garrard M; Chiang YW; Prausnitz MR
J Control Release; 2016 Oct; 239():19-26. PubMed ID: 27524283
[TBL] [Abstract][Full Text] [Related]
33. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
[TBL] [Abstract][Full Text] [Related]
34. DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen.
Cole G; Ali AA; McErlean E; Mulholland EJ; Short A; McCrudden CM; McCaffrey J; Robson T; Kett VL; Coulter JA; Dunne NJ; Donnelly RF; McCarthy HO
Acta Biomater; 2019 Sep; 96():480-490. PubMed ID: 31299353
[TBL] [Abstract][Full Text] [Related]
35. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.
Matsuo K; Hirobe S; Okada N; Nakagawa S
Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401
[TBL] [Abstract][Full Text] [Related]
36. In vitro characterization of the invasiveness of polymer microneedle against skin.
Noh YW; Kim TH; Baek JS; Park HH; Lee SS; Han M; Shin SC; Cho CW
Int J Pharm; 2010 Sep; 397(1-2):201-5. PubMed ID: 20619328
[TBL] [Abstract][Full Text] [Related]
37. Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice.
Lee IC; Lin WM; Shu JC; Tsai SW; Chen CH; Tsai MT
J Biomed Mater Res A; 2017 Jan; 105(1):84-93. PubMed ID: 27539509
[TBL] [Abstract][Full Text] [Related]
38. Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice.
Nakatsukasa A; Kuruma K; Okamatsu M; Hiono T; Suzuki M; Matsuno K; Kida H; Oyamada T; Sakoda Y
Vaccine; 2017 May; 35(21):2855-2861. PubMed ID: 28431812
[TBL] [Abstract][Full Text] [Related]
39. Transcutaneous vaccination via laser microporation.
Weiss R; Hessenberger M; Kitzmüller S; Bach D; Weinberger EE; Krautgartner WD; Hauser-Kronberger C; Malissen B; Boehler C; Kalia YN; Thalhamer J; Scheiblhofer S
J Control Release; 2012 Sep; 162(2):391-9. PubMed ID: 22750193
[TBL] [Abstract][Full Text] [Related]
40. Microneedle patch designs to increase dose administered to human subjects.
Li W; Li S; Fan X; Prausnitz MR
J Control Release; 2021 Nov; 339():350-360. PubMed ID: 34597745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
